Showing 1951-1960 of 3139 results for "".
- FDA Panel Urges Removal of Talc from Consumer Products Due to Cancer Linkhttps://modernaesthetics.com/news/fda-panel-urges-removal-of-talc-from-consumer-products-due-to-cancer-link/2475371/A U.S. Food and Drug Administration (FDA) advisory panel has reinforced longstanding concerns over the carcinogenic potential of talc, urging the agency to restrict its use in foods, drugs, and cosmetics. Citing more
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glutathio
- New Artificial Intelligence Platform to Enhance Leads, Conversions, and Retention for Private-Pay Clinicshttps://modernaesthetics.com/news/new-artificial-intelligence-platform-to-enhance-leads-conversions-and-retention-for-private-pay-clinics/2475367/BoomerangFX announced the global launch of LeadEngineAITM, an AI-powered platform designed to streamline and automate lead generation and conversion for private-pay healthcare clinics. A press release from the manufacturer said that the tool integrates marketing automation, CR
- Skin Clique Expands Virtual Services with Nationwide Esthetician Programhttps://modernaesthetics.com/news/skin-clique-expands-virtual-services-with-nationwide-esthetician-program/2475363/Skin Clique, a physician-founded aesthetic care provider, has launched a virtual Esthetician Program to expand access to individualized skincare consultations across the United States. The program integrates licensed estheticians into the company’s existin
- Federal Court Rules In Favor Of Permanent Injunction In InMode Counterfeit Device Casehttps://modernaesthetics.com/news/federal-court-grants-permanent-injection-to-inmode-in-counterfeit-device-case/2475361/The U.S. District Court for the Central District of California has ruled in favor of InMode Ltd., granting a default judgment against multiple DHGate sellers accused of promoting and distributing counterfeit aesthetic medical devices, the company announced in a press release. In its May 6
- BOTOX® Cosmetic Expands Support Program for Women Entrepreneurs with 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-expands-support-program-for-women-with-2025-confidence-project/2475360/Allergan Aesthetics, an AbbVie company, has announced the return and expansion of its initiative aimed at addressing the “Confidence Gap” among women entrepreneurs. The 2025 edition of The Confidence Project: Empowering Women Entrepreneurs will support 250 founders through mentorship and business
- Men’s Aesthetic Practice Announces New Chief Medical Director for San Diego Clinichttps://modernaesthetics.com/news/mens-aesthetic-practice-announces-new-chief-medical-director-for-san-diego-clinic/2475355/Lushful Aesthetics, a leader in specialized sexual health and enhancement procedures, named Dr. Carlton Thomas as chief medical director of its new clinic in San Diego. Dr. Thomas will oversee medical operations next to Lushful Aesthetics founder Chris Bustamante, DNP, NP-C. Dr. Thomas gai
- iS Clinical Executives Explain Impact of New Peel Systemhttps://modernaesthetics.com/news/is-clinical-executives-explain-impact-of-new-peel-system/2475354/The next evolution of iS Clinical’s Active Peel System is the iS Clinical Extra Strength Active Peel Brightening System, which launched this week exclusively through authorized iS Clinical professionals nationwide, the company announced. The system’s professional-grade results include three times
- Candela Launches Dual-Wavelength Vbeam Pro for Vascular and Dermatologic Conditionshttps://modernaesthetics.com/news/candela-launches-dual-wavelength-vbeam-pro-for-vascular-and-dermatologic-conditions/2475352/Candela has introduced its latest pulsed dye laser platform, the Vbeam Pro, at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) in Orlando, Florida. The new system is FDA-cleared
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types